Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study to Reinforce Immunity (STRI) for COVID-19
NCT05046561Phase 2Unknown
- Start
- Nov 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of QuadraMune in coronavirus disease 2019 (COVID-19). Status: unknown.
02
Drugs
QuadraMune
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05046561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05046561.